Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 467 entries
View as:

Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT02970448 Org: User:
Start: 08/24/17 End: 10/25/24 Due: 10/25/25

O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00002604 Org: User:
Start: 01/31/96 End: 02/29/04 Due: 02/28/05

Radiosurgery in Treating Patients With Kidney Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00458484 Org: User:
Start: 02/20/07 End: 09/12/19 Due: 09/12/20

Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00740961 Org: User:
Start: 03/31/08 End: 09/30/11 Due: 09/30/12

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06263088 Org: User:
Start: 12/01/24 End: 06/30/26 Due: 06/30/27

Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05970107 Org: User:
Start: 10/31/25 End: 09/01/28 Due: 09/01/29

Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01045928 Org: User:
Start: 01/31/10 End: 03/31/12 Due: 03/31/13

Optimal Timing of Postoperative Magnetic Resonance Imaging (MRI) in Patients With Extradural Spinal

Phase: N/A Priority: Normal
NCT ID: NCT02790294 Org: User:
Start: 08/31/16 End: 12/17/20 Due: 12/17/21

Development of MRF for Characterization of Brain Tumors After Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06101069 Org: User:
Start: 10/14/24 End: 06/30/26 Due: 06/30/27

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01165996 Org: User:
Start: 07/31/10 End: 08/31/12 Due: 08/31/13

Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program

Phase: N/A Priority: Normal
NCT ID: NCT02419846 Org: User:
Start: 06/01/15 End: 07/31/22 Due: 07/31/23

Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00732173 Org: User:
Start: 07/31/08 End: 03/31/11 Due: 03/31/12

Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI

Phase: N/A Priority: Normal
NCT ID: NCT07040501 Org: User:
Start: 09/30/25 End: 01/31/26 Due: 01/31/27

Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning

Phase: N/A Priority: Normal
NCT ID: NCT02681614 Org: User:
Start: 07/21/16 End: 02/11/18 Due: 02/11/19

Getting Ahead for Cancer Control

Phase: N/A Priority: Normal
NCT ID: NCT03247634 Org: User:
Start: 12/08/17 End: 03/04/20 Due: 03/04/21

Lavender Oil Aromatherapy for The Treatment of Acute Anxiety During Bone Marrow Biopsy Procedures

Phase: N/A Priority: Normal
NCT ID: NCT05102331 Org: User:
Start: 08/31/21 End: 08/31/22 Due: 08/31/23

Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02319889 Org: User:
Start: 02/02/16 End: 01/19/17 Due: 01/19/18

Menopausal Symptoms in Women With Breast Cancer or At High Risk of Breast Cancer Treated on Another Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT00666913 Org: User:
Start: 10/31/07 End: 06/30/10 Due: 06/30/11

Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00028665 Org: User:
Start: 06/30/00 End: - Due: -

Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02768389 Org: User:
Start: 09/06/16 End: 11/30/18 Due: 11/30/19

Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions

Phase: N/A Priority: Normal
NCT ID: NCT02802553 Org: User:
Start: 12/28/17 End: 12/31/24 Due: 12/31/25

Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00281840 Org: User:
Start: 09/30/05 End: 12/31/12 Due: 12/31/13

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01973062 Org: User:
Start: 03/31/14 End: 06/30/15 Due: 06/30/16

Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00055640 Org: User:
Start: 10/31/02 End: 03/31/06 Due: 03/31/07

Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer

Phase: N/A Priority: Normal
NCT ID: NCT03135392 Org: User:
Start: 10/31/18 End: 10/31/20 Due: 10/31/21